Product Code: 978-1-68038-670-7
Transcatheter Embolization And Occlusion Devices Market Growth & Trends:
The global transcatheter embolization and occlusion devices market size is expected to reach USD 8.54 billion by 2030, registering a CAGR of 7.0% from 2023 to 2030, according to a new report by Grand View Research, Inc.. The global market is anticipated to register a strong CAGR of 9.7% from 2019 to 2026. Key drivers of the TEO devices market include increasing adoption of minimally invasive surgeries and rising prevalence of cancer.
In addition, wide usage of embolization technique as a treatment for conditions other than cancer, such as vascular malformations and fibrosis, is fueling the demand for TEO devices globally. Furthermore, introduction of technically advanced products with enhanced efficiency is supporting the global market growth. On the other hand, high cost, stringent regulatory approval procedures, and requirement of experienced healthcare professionals to perform TEO procedures are some of the factors that may have a negative impact on the market development.
Asia Pacific TEO devices market is anticipated to witness highest CAGR from 2019 to 2026 due to increasing healthcare expenditure and improving healthcare infrastructure. Rapid expansion of medical tourism industry in the emerging countries of APAC is also boosting the demand for TEO devices. Brazil was the highest revenue-generating country in Latin America in 2018. Improving healthcare services, growing medical tourism industry, and availability of regulatory framework in the country are further driving the market in Brazil
Transcatheter Embolization And Occlusion Devices Market Report Highlights:
- Coils accounted for the largest share. Availability of a broad range of coils in various shapes and sizes enables suitable product selection for different cases, making coiling a preferred treatment for embolization
- Moreover, affordability of the commercially available devices spurs demand for coiling in occlusion
- Accessories is expected to be the largest type segment due to wide usage of accessories across various modes of embolization and occlusion
- North America along with Europe accounted for the largest share in 2022. Presence of advanced healthcare infrastructure, reimbursement coverage, and skilled professionals to perform procedures are some of the factors driving the growth of these regionsm
- Moreover, quick adoption of advanced healthcare treatments and products coupled with the presence of well-defined regulatory framework are boosting North America and Europe markets
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Product
- 1.1.2. Application
- 1.1.3. Regional scope
- 1.1.4. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.4. Information or Data Analysis
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product outlook
- 2.2.2. Application outlook
- 2.2.3. Regional outlook
- 2.3. Competitive Insights
Chapter 3. Transcatheter Embolization and Occlusion Devices Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Market Dynamics
- 3.3.1. Market driver analysis
- 3.3.2. Market restraint analysis
- 3.4. Transcatheter Embolization and Occlusion Devices Market Analysis Tools
- 3.4.1. Industry Analysis - Porter's Five Forces
- 3.4.1.1. Supplier power
- 3.4.1.2. Buyer power
- 3.4.1.3. Substitution threat
- 3.4.1.4. Threat of new entrant
- 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
- 3.4.2.1. Political landscape
- 3.4.2.2. Technological landscape
- 3.4.2.3. Economic landscape
Chapter 4. Transcatheter Embolization and Occlusion Devices Market: Product Estimates & Trend Analysis
- 4.1. Transcatheter Embolization and Occlusion Devices Market: Key Takeaways
- 4.2. Transcatheter Embolization and Occlusion Devices Market: Product Movement & Market Share Analysis, 2022 & 2030
- 4.3. Coil
- 4.3.1. Coil market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.3.2. Pushable coils
- 4.3.2.1. Pushable coils market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.3.3. Detachable coils
- 4.3.3.1. Detachable coils market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4. Non Coil
- 4.4.1. Non coil market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.2. Flow diverting devices
- 4.4.2.1. Flow diverting devices market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.3. Embolization particles
- 4.4.3.1. Embolization particles market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.4. Liquid embolics
- 4.4.4.1. Liquid embolics market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.5. Other embolization and occlusion devices
- 4.4.5.1. Other embolization and occlusion devices market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.6. Accessories
- 4.4.6.1. Accessories market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Transcatheter Embolization and Occlusion Devices Market: Application Estimates & Trend Analysis
- 5.1. Transcatheter Embolization and Occlusion Devices Market: Key Takeaways
- 5.2. Transcatheter Embolization and Occlusion Devices Market: Application Movement & Market Share Analysis, 2022 & 2030
- 5.3. Peripheral Vascular Disease
- 5.3.1. Peripheral vascular disease market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.3.2. Arterial blockage
- 5.3.2.1. Arterial blockage market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.3.3. Venous blood clot
- 5.3.3.1. Venous blood clot market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.3.4. Others
- 5.3.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.4. Oncology
- 5.4.1. Oncology market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.4.2. Liver cancer
- 5.4.2.1. Liver cancer market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.4.3. Pancreatic cancer
- 5.4.3.1. Pancreatic cancer market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.4.4. Breast cancer
- 5.4.4.1. Breast cancer market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.4.5. Kidney cancer
- 5.4.5.1. Kidney cancer market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.4.6. Others
- 5.4.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.5. Neurology
- 5.5.1. Neurology market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.5.2. Brain aneurysm
- 5.5.2.1. Brain aneurysm market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.5.3. Cerebral arteriovenous malformations
- 5.5.3.1. Cerebral arteriovenous malformations market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.5.4. Others
- 5.5.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.6. Urology
- 5.6.1. Urology market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.6.2. Benign prostatic hyperplasia/urinary retention
- 5.6.2.1. Benign prostatic hyperplasia/urinary retention market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.6.3. Others
- 5.6.3.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.7. Others
- 5.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Transcatheter Embolization and Occlusion Devices Market: Regional Estimates & Trend Analysis
- 6.1. Regional Outlook
- 6.2. Transcatheter Embolization and Occlusion Devices Market by Region: Key Takeaway
- 6.3. North America
- 6.3.1. North America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.3.2. U.S.
- 6.3.2.1. U.S. market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.3.3. Canada
- 6.3.3.1. Canada market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4. Europe
- 6.4.1. Europe market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.2. UK
- 6.4.2.1. UK market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.3. Germany
- 6.4.3.1. Germany market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.4. France
- 6.4.4.1. France market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.5. Italy
- 6.4.5.1. Italy market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.6. Spain
- 6.4.6.1. Spain market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.7. Sweden
- 6.4.7.1. Sweden market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.8. Norway
- 6.4.8.1. Norway market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.4.9. Denmark
- 6.4.9.1. Denmark market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5. Asia Pacific
- 6.5.1. Asia Pacific market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.2. Japan
- 6.5.2.1. Japan market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.3. China
- 6.5.3.1. China market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.4. India
- 6.5.4.1. India market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.5. Australia
- 6.5.5.1. Australia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.6. Thailand
- 6.5.6.1. Thailand market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.5.7. South Korea
- 6.5.7.1. South Korea market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.6. Latin America
- 6.6.1. Latin America market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.6.2. Brazil
- 6.6.2.1. Brazil market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.6.3. Mexico
- 6.6.3.1. Mexico market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.6.4. Argentina
- 6.6.4.1. Argentina market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.7. MEA
- 6.7.1. MEA market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.7.2. Saudi Arabia
- 6.7.2.1. Saudi Arabia market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.7.3. South Africa
- 6.7.3.1. South Africa market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.7.4. UAE
- 6.7.4.1. UAE market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
- 6.7.5. Kuwait
- 6.7.5.1. Kuwait market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 7. Competitive Landscape
- 7.1. Recent Developments & Impact Analysis, By Key Market Participants
- 7.2. Market Participant Categorization
- 7.2.1. Boston Scientific Corporation
- 7.2.1.1. Company overview
- 7.2.1.2. Financial performance
- 7.2.1.3. Product benchmarking
- 7.2.1.4. Strategic initiatives
- 7.2.2. Terumo Corporation
- 7.2.2.1. Company overview
- 7.2.2.2. Financial performance
- 7.2.2.3. Product benchmarking
- 7.2.2.4. Strategic initiatives
- 7.2.3. Medtronic
- 7.2.3.1. Company overview
- 7.2.3.2. Financial performance
- 7.2.3.3. Product benchmarking
- 7.2.3.4. Strategic initiatives
- 7.2.4. DePuy Synthes
- 7.2.4.1. Company overview
- 7.2.4.2. Financial performance
- 7.2.4.3. Product benchmarking
- 7.2.4.4. Strategic initiatives
- 7.2.5. Stryker
- 7.2.5.1. Company overview
- 7.2.5.2. Financial performance
- 7.2.5.3. Product benchmarking
- 7.2.5.4. Strategic initiatives
- 7.2.6. Cordis
- 7.2.6.1. Company overview
- 7.2.6.2. Financial performance
- 7.2.6.3. Product benchmarking
- 7.2.6.4. Strategic initiatives
- 7.2.7. Abbott
- 7.2.7.1. Company overview
- 7.2.7.2. Financial performance
- 7.2.7.3. Product benchmarking
- 7.2.7.4. Strategic initiatives
- 7.2.8. Pfizer Inc.
- 7.2.8.1. Company overview
- 7.2.8.2. Financial performance
- 7.2.8.3. Product benchmarking
- 7.2.8.4. Strategic initiatives
- 7.2.9. Sirtex
- 7.2.9.1. Company overview
- 7.2.9.2. Financial performance
- 7.2.9.3. Product benchmarking
- 7.2.9.4. Strategic initiatives
- 7.2.10. Nordion
- 7.2.10.1. Company overview
- 7.2.10.2. Financial performance
- 7.2.10.3. Product benchmarking
- 7.2.10.4. Strategic initiatives